Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis

J K L Gunn, C B Rosales, K E Center, A Nuñez, S J Gibson, C Christ, J E Ehiri, J K L Gunn, C B Rosales, K E Center, A Nuñez, S J Gibson, C Christ, J E Ehiri

Abstract

Objective: To assess the effects of use of cannabis during pregnancy on maternal and fetal outcomes.

Data sources: 7 electronic databases were searched from inception to 1 April 2014. Studies that investigated the effects of use of cannabis during pregnancy on maternal and fetal outcomes were included.

Study selection: Case-control studies, cross-sectional and cohort studies were included.

Data extraction and synthesis: Data synthesis was undertaken via systematic review and meta-analysis of available evidence. All review stages were conducted independently by 2 reviewers.

Main outcomes and measures: Maternal, fetal and neonatal outcomes up to 6 weeks postpartum after exposure to cannabis. Meta-analyses were conducted on variables that had 3 or more studies that measured an outcome in a consistent manner. Outcomes for which meta-analyses were conducted included: anaemia, birth weight, low birth weight, neonatal length, placement in the neonatal intensive care unit, gestational age, head circumference and preterm birth.

Results: 24 studies were included in the review. Results of the meta-analysis demonstrated that women who used cannabis during pregnancy had an increase in the odds of anaemia (pooled OR (pOR)=1.36: 95% CI 1.10 to 1.69) compared with women who did not use cannabis during pregnancy. Infants exposed to cannabis in utero had a decrease in birth weight (low birth weight pOR=1.77: 95% CI 1.04 to 3.01; pooled mean difference (pMD) for birth weight=109.42 g: 38.72 to 180.12) compared with infants whose mothers did not use cannabis during pregnancy. Infants exposed to cannabis in utero were also more likely to need placement in the neonatal intensive care unit compared with infants whose mothers did not use cannabis during pregnancy (pOR=2.02: 1.27 to 3.21).

Conclusions and relevance: Use of cannabis during pregnancy may increase adverse outcomes for women and their neonates. As use of cannabis gains social acceptance, pregnant women and their medical providers could benefit from health education on potential adverse effects of use of cannabis during pregnancy.

Keywords: PREVENTIVE MEDICINE; PUBLIC HEALTH.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Figures

Figure 1
Figure 1
Flow of studies through the review process. ICU, intensive care unit; NICU, neonatal intensive care unit.

References

    1. WHO. Management of substance abuse: Cannabis. 7 July 2015.
    1. Crime, U.N.O.o.D.a. World drug report. 2014.
    1. Degenhardt L, Whiteford H, Hall WD. The Global Burden of Disease projects: what have we learned about illicit drug use and dependence and their contribution to the global burden of disease? Drug Alcohol Rev 2014;33:4–12. 10.1111/dar.12088
    1. Board, I.N.C, U.N.V.I. Centre, and Austria. International Narcotics Control Board: 2013 Annual Report, 2013.
    1. English D, Hulse GK, Milne E et al. . Maternal cannabis use and birth weight: a meta-analysis. Addiction 1997;92:1553–60. 10.1111/j.1360-0443.1997.tb02875.x
    1. Gunn JK, Rosales CB, Center KE et al. . The effects of prenatal cannabis exposure on fetal development and pregnancy outcomes: a protocol. BMJ open 2015;5:e007227 10.1136/bmjopen-2014-007227
    1. Health, N.C.C.f.E. and (NCCEH). A Primer for Evaluating the Quality of Studies onEnvironmental Health Critical Appraisal of Cross-Sectional Studies 2011. (updated 5 June 2014).
    1. UK, C.A.S.P.C. Making sense of evidence: 12 questions to help you make sense of a cohort study. 2013. (cited Nov 2014).
    1. UK, C.A.S.P.C. Making sense of evidence: 11 questions to help you make sense of a case control study. 2013.
    1. Cochran WG. The combination of estimates from different experiments. Biometrics 1954;10:101–29. 10.2307/3001666
    1. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539–58. 10.1002/sim.1186
    1. Review Manager (RevMan). 2014, Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration.
    1. Greenland S, Staisch KJ, Brown N et al. . Effects of marijuana on human pregnancy, labor, and delivery. Neurobehav Toxicol Teratol 1982;4:447–50.
    1. WHO. Development of indicators for monitoring progress towards health for all by the year 2000. 1981 (cited Sept 2015) .
    1. Wardlaw TM. Low birthweight: country, regional and global estimates. UNICEF, 2004.
    1. Bonello MR, Xu F, Li Z et al. . Mental and behavioral disorders due to substance abuse and perinatal outcomes: a study based on linked population data in New South Wales, Australia. Int J Environ Res Public Health 2014;11:4991–5005. 10.3390/ijerph110504991
    1. Gargari SS, Fallahian M, Haghighi L et al. . Maternal and neonatal complications of substance abuse in Iranian pregnant women. Acta Med Iran 2012;50:411–16.
    1. Hayatbakhsh MR, Flenady VJ, Gibbons KS et al. . Birth outcomes associated with cannabis use before and during pregnancy. Pediatr Res 2012;71:215–19. 10.1038/pr.2011.25
    1. Lozano J, García-A-Algar O, Marchei E et al. . Prevalence of gestational exposure to cannabis in a Mediterranean city by meconium analysis. Acta Paediatr 2007;96:1734–7. 10.1111/j.1651-2227.2007.00535.x
    1. Ostrea EM, Ostrea AR, Simpson PM. Mortality within the first 2 years in infants exposed to cocaine, opiate, or cannabinoid during gestation. Pediatrics 1997;100:79–83. 10.1542/peds.100.1.79
    1. Quinlivan JA, Evans SF. The impact of continuing illegal drug use on teenage pregnancy outcomes—a prospective cohort study. BJOG 2002;109:1148–53.
    1. Witter FR. Niebyl JR. Marijuana use in pregnancy and pregnancy outcome. Am J Perinatol 1990;7:36–8. 10.1055/s-2007-999442
    1. [No authors listed] WHO: recommended definitions, terminology and format for statistical tables related to the perinatal period and use of a new certificate for cause of perinatal deaths. Modifications recommended by FIGO as amended October 14, 1976. Acta Obstet Gynecol Scand 1977;56:247–53.
    1. Berenson AB, Wilkinson GS, Lopez LA. Effects of prenatal care on neonates born to drug-using women. Subst Use Misuse 1996;31:1063–76. 10.3109/10826089609072288
    1. Ammenheuser MM, Berenson AB, Babiak AE et al. . Frequencies of hprt mutant lymphocytes in marijuana-smoking mothers and their newborns. Mut Res 1998;403:55–64. 10.1016/S0027-5107(98)00027-X
    1. de Moraes Barros MC, Guinsburg R, De Araújo Peres C et al. . Exposure to marijuana during pregnancy alters neurobehavior in the early neonatal period. J Pediatr 2006;149:781–7. 10.1016/j.jpeds.2006.08.046
    1. Braunstein GD, Buster JE, Soares JR et al. . Pregnancy hormone concentrations in marijuana users. Life Sci 1983;33:195–9. 10.1016/0024-3205(83)90413-7
    1. Chasnoff IJ, Griffith DR, Freier C et al. . Cocaine/polydrug use in pregnancy: two-year follow-up. Pediatrics 1992;89:284–9.
    1. El Marroun H, Tiemeier H, Steegers EA et al. . Intrauterine cannabis exposure affects fetal growth trajectories: the Generation R Study. J Am Acad Child Adolesc Psychiatry 2009;48:1173–81. 10.1097/CHI.0b013e3181bfa8ee
    1. El Marroun H, Tiemeier H, Steegers EA et al. . A prospective study on intrauterine cannabis exposure and fetal blood flow. Early Hum Dev 2010;86:231–6. 10.1016/j.earlhumdev.2010.03.006
    1. Fried P, Watkinson B, Willan A. Marijuana use during pregnancy and decreased length of gestation. Am J Obstet Gynecol 1984;150:23–7. 10.1016/S0002-9378(84)80103-9
    1. Fried PA, Watkinson B, Dillon RF et al. . Neonatal neurological status in a low-risk population after prenatal exposure to cigarettes, marijuana, and alcohol. J Dev Behav Pediatr 1987;8:318–26. 10.1097/00004703-198712000-00003
    1. Fried PA, Makin J. Neonatal behavioural correlates of prenatal exposure to marihuana, cigarettes and alcohol in a low risk population. Neurotoxicol Teratol 1987;9:1–7. 10.1016/0892-0362(87)90062-6
    1. Fried PA. Marijuana use during pregnancy: consequences for the offspring. Semin Perinatol 1991;15:280–7.
    1. Fried PA, Watkinson B, Gray R. Growth from birth to early adolescence in offspring prenatally exposed to cigarettes and marijuana. Neurotoxicol Teratol 1999;21:513–25. 10.1016/S0892-0362(99)00009-4
    1. Greenland S, Richwald GA, Honda GD. The effects of marijuana use during pregnancy. II. A study in a low-risk home-delivery population. Drug Alcohol Depend 1983;11:359–66. 10.1016/0376-8716(83)90026-1
    1. Hayes JS, Lampart R, Dreher MC et al. . Five-year follow-up of rural Jamaican children whose mothers used marijuana during pregnancy. West Indian Med J 1991;40:120–3.
    1. Kline J, Hutzler M, Levin B et al. . Marijuana and spontaneous abortion of known karyotype. Paediatr Perinat Epidemiol 1991;5:320–32. 10.1111/j.1365-3016.1991.tb00717.x
    1. Shankaran S, Das A, Bauer CR et al. . Association between patterns of maternal substance use and infant birth weight, length, and head circumference. Pediatrics 2004;114:e226–34. 10.1542/peds.114.2.e226
    1. Fried P, Buckingham M, Von Kulmiz P. Marijuana use during pregnancy and perinatal risk factors. Am J Obstet Gynecol 1983;146:992–4.
    1. Nosyk B, Wood E, Kerr T. The rise of marijuana and the fall of cocaine in the United States: for better, for worse? Addiction 2015;110:737–8. 10.1111/add.12738
    1. McCormick MC. The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med 1985;312:82–90. 10.1056/NEJM198501103120204
    1. Horbar JD, Carpenter JH, Badger GJ et al. . Mortality and neonatal morbidity among infants 501 to 1500 grams from 2000 to 2009. Pediatrics 2012;129:1019–26. 10.1542/peds.2011-3028
    1. Hack M, Flannery DJ, Schluchter M et al. . Outcomes in young adulthood for very-low-birth-weight infants. N Engl J Med 2002;346:149–57. 10.1056/NEJMoa010856
    1. Black SE, Devereux PJ, Salvanes K. From the cradle to the labor market? The effect of birth weight on adult outcomes. National Bureau of Economic Research, 2005.
    1. Hack M, Youngstrom EA, Cartar L et al. . Behavioral outcomes and evidence of psychopathology among very low birth weight infants at age 20 years. Pediatrics 2004;114:932–40. 10.1542/peds.2003-1017-L
    1. Cömert S, Ağzıkuru T, Akin Y et al. . The cost analysis of preterm infants from a NICU of a state hospital in Istanbul. Iran J Pediatr 2012;22:185.
    1. Cheah IG, Soosai AP, Wong SL et al. . Cost-effectiveness analysis of Malaysian neonatal intensive care units. J Perinatol 2005;25:47–53. 10.1038/sj.jp.7211196
    1. Profit J, Lee D, Zupancic JA et al. . Clinical benefits, costs, and cost-effectiveness of neonatal intensive care in Mexico. PLoS Med 2010;7:e1000379 10.1371/journal.pmed.1000379
    1. Prinja S, Manchanda N, Mohan P et al. . Cost of neonatal intensive care delivered through district level public hospitals in India. Indian Pediatr 2013;50:839–46. 10.1007/s13312-013-0234-6
    1. Jaques SC, Kingsbury A, Henshcke P et al. . Cannabis, the pregnant woman and her child: weeding out the myths. J Perinatol 2014;34:417–24. 10.1038/jp.2013.180
    1. Patra J, Bakker R, Irving H et al. . Dose–response relationship between alcohol consumption before and during pregnancy and the risks of low birthweight, preterm birth and small for gestational age (SGA)-a systematic review and meta-analyses. BJOG 2011;118:1411–21. 10.1111/j.1471-0528.2011.03050.x
    1. Janisse JJ, Bailey BA, Ager J et al. . Alcohol, tobacco, cocaine, and marijuana use: relative contributions to preterm delivery and fetal growth restriction. Subst Abus 2014;35:60–7. 10.1080/08897077.2013.804483

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe